These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 28000240

  • 1. Epidermal programmed cell death-ligand 1 expression in TEN associated with nivolumab therapy.
    Vivar KL, Deschaine M, Messina J, Divine JM, Rabionet A, Patel N, Harrington MA, Seminario-Vidal L.
    J Cutan Pathol; 2017 Apr; 44(4):381-384. PubMed ID: 28000240
    [Abstract] [Full Text] [Related]

  • 2. Toxic Epidermal Necrolysis-like Reaction With Severe Satellite Cell Necrosis Associated With Nivolumab in a Patient With Ipilimumab Refractory Metastatic Melanoma.
    Nayar N, Briscoe K, Fernandez Penas P.
    J Immunother; 2016 Apr; 39(3):149-52. PubMed ID: 26938948
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and Safety of Nivolumab in Patients With BRAF V600 Mutant and BRAF Wild-Type Advanced Melanoma: A Pooled Analysis of 4 Clinical Trials.
    Larkin J, Lao CD, Urba WJ, McDermott DF, Horak C, Jiang J, Wolchok JD.
    JAMA Oncol; 2015 Jul; 1(4):433-40. PubMed ID: 26181250
    [Abstract] [Full Text] [Related]

  • 4. Combination Therapy of Ipilimumab and Nivolumab-associated Toxic Epidermal Necrolysis (TEN) in a Patient With Metastatic Melanoma: A Case Report and Literature Review.
    Logan IT, Zaman S, Hussein L, Perrett CM.
    J Immunother; 2020 Apr; 43(3):89-92. PubMed ID: 31651559
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Vemurafenib-induced toxic epidermal necrolysis].
    Wantz M, Spanoudi-Kitrimi I, Lasek A, Lebas D, Quinchon JF, Modiano P.
    Ann Dermatol Venereol; 2014 Mar; 141(3):215-8. PubMed ID: 24635957
    [Abstract] [Full Text] [Related]

  • 7. Stevens-Johnson syndrome/toxic epidermal necrolysis mouse model generated by using PBMCs and the skin of patients.
    Saito N, Yoshioka N, Abe R, Qiao H, Fujita Y, Hoshina D, Suto A, Kase S, Kitaichi N, Ozaki M, Shimizu H.
    J Allergy Clin Immunol; 2013 Feb; 131(2):434-41.e1-9. PubMed ID: 23111236
    [Abstract] [Full Text] [Related]

  • 8. PD-1 inhibition in congenital pigment synthesizing metastatic melanoma.
    Weyand AC, Mody RJ, Rabah RM, Opipari VP.
    Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28675691
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cytotoxic Cutaneous Adverse Drug Reactions during Anti-PD-1 Therapy.
    Goldinger SM, Stieger P, Meier B, Micaletto S, Contassot E, French LE, Dummer R.
    Clin Cancer Res; 2016 Aug 15; 22(16):4023-9. PubMed ID: 26957557
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Subacute CNS Demyelination after Treatment with Nivolumab for Melanoma.
    Maurice C, Schneider R, Kiehl TR, Bavi P, Roehrl MH, Mason WP, Hogg D.
    Cancer Immunol Res; 2015 Dec 15; 3(12):1299-302. PubMed ID: 26419960
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Adverse Reactions to Biologics: Melanoma (Ipilimumab, Nivolumab, Pembrolizumab).
    Hwang SJE, Fernández-Peñas P.
    Curr Probl Dermatol; 2018 Dec 15; 53():82-92. PubMed ID: 29131040
    [Abstract] [Full Text] [Related]

  • 19. Nivolumab in melanoma.
    Specenier P.
    Expert Rev Anticancer Ther; 2016 Dec 15; 16(12):1247-1261. PubMed ID: 27776441
    [Abstract] [Full Text] [Related]

  • 20. Nivolumab in previously untreated melanoma without BRAF mutation.
    Robert C, Long GV, Brady B, Dutriaux C, Maio M, Mortier L, Hassel JC, Rutkowski P, McNeil C, Kalinka-Warzocha E, Savage KJ, Hernberg MM, Lebbé C, Charles J, Mihalcioiu C, Chiarion-Sileni V, Mauch C, Cognetti F, Arance A, Schmidt H, Schadendorf D, Gogas H, Lundgren-Eriksson L, Horak C, Sharkey B, Waxman IM, Atkinson V, Ascierto PA.
    N Engl J Med; 2015 Jan 22; 372(4):320-30. PubMed ID: 25399552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.